Not available outside of the UK & Ireland.
Analysis Note
ControlHEK293 cell lysate
Application
ELISA: A 1:1000 dilution of a previous lot was used on ELISA.
Research Sub CategoryHistones
Anti-PADI4 Antibody, C-terminus is an antibody against PADI4 for use in WB, ELISA.
Research CategoryEpigenetics & Nuclear Function
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
PADI4 (Protein-arginine deiminase type-4) is a member of a family of enzymes responsible for the conversion of arginine residues to citrulline residues via catalysis of the deimination of the arginine residues. PADI4 down-regulates histone H3 and H4 arginine methylation, both by preventing arginine methylation by CARM1 and HRMT1L2/PRMT1 and by converting methylarginine to citrulline. This protein may play a role in granulocyte and macrophage development leading to inflammation and immune response.
Immunogen
Epitope: C-terminus
KLH-conjugated synthetic linear peptide corresponding to the C-terminal region of PADI4.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Format: Purified
Purified rabbit polyclonal in buffer containing PBS and 0.09% sodium azide.
Quality
Evaluated by western blot on HEK293 cell lysate.
Western Blotting Analysis: 1:25-1:500 dilution of this antibody detected PADI4 in HEK293 cell lysate.
Specificity
The antibody recognizes PADI4 at and around the C-terminus.
Storage and Stability
Stable for 6 months at 2-8°C from date of receipt. For long term storage, store at -20°C
Target description
~74 kDa
This product has met the following criteria to qualify for the following awards: